158 related articles for article (PubMed ID: 21505696)
21. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
22. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
23. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
24. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
25. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
26. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
27. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
Sanderson RD; Yang Y; Suva LJ; Kelly T
Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
[TBL] [Abstract][Full Text] [Related]
28. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase.
Hulett MD; Hornby JR; Ohms SJ; Zuegg J; Freeman C; Gready JE; Parish CR
Biochemistry; 2000 Dec; 39(51):15659-67. PubMed ID: 11123890
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the specificity of heparanase utilizing synthetic substrates.
Peterson SB; Liu J
J Biol Chem; 2010 May; 285(19):14504-13. PubMed ID: 20181948
[TBL] [Abstract][Full Text] [Related]
30. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
Chhabra M; Ferro V
Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
[TBL] [Abstract][Full Text] [Related]
31. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
32. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
[TBL] [Abstract][Full Text] [Related]
33. Subcellular localization of human heparanase and its alternative splice variant in COS-7 cells.
Sato M; Amemiya K; Hayakawa S; Munakata H
Cell Biochem Funct; 2008 Aug; 26(6):676-83. PubMed ID: 18646256
[TBL] [Abstract][Full Text] [Related]
34. High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents.
Huang KS; Holmgren J; Reik L; Lucas-McGady D; Roberts J; Liu CM; Levin W
Anal Biochem; 2004 Oct; 333(2):389-98. PubMed ID: 15450817
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
36. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
37. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
38. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
39. Production of heparanase constructs suitable for nuclear magnetic resonance and drug discovery studies.
Mosulén S; Ortí L; Bas E; Carbajo RJ; Pineda-Lucena A
Biopolymers; 2011 Feb; 95(2):151-60. PubMed ID: 20882536
[TBL] [Abstract][Full Text] [Related]
40. Function of heparanase in prostate tumorigenesis: potential for therapy.
Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
